229 related articles for article (PubMed ID: 32105723)
1. Digital UV/VIS imaging: A rapid PAT tool for crushing strength, drug content and particle size distribution determination in tablets.
Mészáros LA; Galata DL; Madarász L; Köte Á; Csorba K; Dávid ÁZ; Domokos A; Szabó E; Nagy B; Marosi G; Farkas A; Nagy ZK
Int J Pharm; 2020 Mar; 578():119174. PubMed ID: 32105723
[TBL] [Abstract][Full Text] [Related]
2. UV/VIS imaging-based PAT tool for drug particle size inspection in intact tablets supported by pattern recognition neural networks.
Mészáros LA; Farkas A; Madarász L; Bicsár R; Galata DL; Nagy B; Nagy ZK
Int J Pharm; 2022 May; 620():121773. PubMed ID: 35487400
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of NIR-chemometric methods for chemical and pharmaceutical characterization of meloxicam tablets.
Tomuta I; Iovanov R; Bodoki E; Vonica L
Drug Dev Ind Pharm; 2014 Apr; 40(4):549-59. PubMed ID: 23594301
[TBL] [Abstract][Full Text] [Related]
4. Machine vision-based non-destructive dissolution prediction of meloxicam-containing tablets.
Alexandra Mészáros L; Madarász L; Kádár S; Ficzere M; Farkas A; Kristóf Nagy Z
Int J Pharm; 2024 Apr; 655():124013. PubMed ID: 38503398
[TBL] [Abstract][Full Text] [Related]
5. Real-time release testing of dissolution based on surrogate models developed by machine learning algorithms using NIR spectra, compression force and particle size distribution as input data.
Galata DL; Könyves Z; Nagy B; Novák M; Mészáros LA; Szabó E; Farkas A; Marosi G; Nagy ZK
Int J Pharm; 2021 Mar; 597():120338. PubMed ID: 33545285
[TBL] [Abstract][Full Text] [Related]
6. Tableting process optimisation with the application of fuzzy models.
Belic A; Skrjanc I; Bozic DZ; Vrecer F
Int J Pharm; 2010 Apr; 389(1-2):86-93. PubMed ID: 20096760
[TBL] [Abstract][Full Text] [Related]
7. Multispectral UV imaging for fast and non-destructive quality control of chemical and physical tablet attributes.
Klukkert M; Wu JX; Rantanen J; Carstensen JM; Rades T; Leopold CS
Eur J Pharm Sci; 2016 Jul; 90():85-95. PubMed ID: 26657202
[TBL] [Abstract][Full Text] [Related]
8. High-throughput NIR-chemometric methods for chemical and pharmaceutical characterization of sustained release tablets.
Porfire A; Filip C; Tomuta I
J Pharm Biomed Anal; 2017 May; 138():1-13. PubMed ID: 28171787
[TBL] [Abstract][Full Text] [Related]
9. Quality by design, part I: application of NIR spectroscopy to monitor tablet manufacturing process.
Tabasi SH; Fahmy R; Bensley D; O'Brien C; Hoag SW
J Pharm Sci; 2008 Sep; 97(9):4040-51. PubMed ID: 18300297
[TBL] [Abstract][Full Text] [Related]
10. Prediction of quality attributes of continuously produced granules using complementary pat tools.
Fonteyne M; Soares S; Vercruysse J; Peeters E; Burggraeve A; Vervaet C; Remon JP; Sandler N; De Beer T
Eur J Pharm Biopharm; 2012 Oct; 82(2):429-36. PubMed ID: 22892292
[TBL] [Abstract][Full Text] [Related]
11. High-throughput NIR-chemometric methods for determination of drug content and pharmaceutical properties of indapamide tablets.
Tomuta I; Rus L; Iovanov R; Rus LL
J Pharm Biomed Anal; 2013 Oct; 84():285-92. PubMed ID: 23347649
[TBL] [Abstract][Full Text] [Related]
12. Effect of excipient particle size distribution variability on compact tensile strength; and its in-line prediction by force-displacement and force-time profiling.
Lee WB; Widjaja E; Heng PWS; Chan LW
Eur J Pharm Sci; 2021 Apr; 159():105703. PubMed ID: 33444745
[TBL] [Abstract][Full Text] [Related]
13. Commercial scale transfer of a twin-screw melt granulation process for high drug load fevipiprant tablets.
Vicente Martin C; Stocker S; Bautista M; Rogue V; Steib-Lauer C; Häcker HG; Spickermann D; Hirsch S; Dhareshwar SS
Drug Dev Ind Pharm; 2022 May; 48(5):211-225. PubMed ID: 35861393
[TBL] [Abstract][Full Text] [Related]
14. Tablet Compression Force as a Process Analytical Technology (PAT): 100% Inspection and Control of Tablet Weight Uniformity.
Manley L; Hilden J; Valero P; Kramer T
J Pharm Sci; 2019 Jan; 108(1):485-493. PubMed ID: 30009799
[TBL] [Abstract][Full Text] [Related]
15. Improving the content uniformity of a low-dose tablet formulation through roller compaction optimization.
am Ende MT; Moses SK; Carella AJ; Gadkari RA; Graul TW; Otano AL; Timpano RJ
Pharm Dev Technol; 2007; 12(4):391-404. PubMed ID: 17763144
[TBL] [Abstract][Full Text] [Related]
16. Analytical comparison between batch and continuous direct compression processes for pharmaceutical manufacturing using an innovative UV-Vis reflectance method and chemometrics.
Macchietti L; Melucci D; Menarini L; Consoli F; Zappi A
Int J Pharm; 2024 May; 656():124090. PubMed ID: 38582101
[TBL] [Abstract][Full Text] [Related]
17. Near-infrared chemical imaging (NIR-CI) as a process monitoring solution for a production line of roll compaction and tableting.
Khorasani M; Amigo JM; Sun CC; Bertelsen P; Rantanen J
Eur J Pharm Biopharm; 2015 Jun; 93():293-302. PubMed ID: 25917640
[TBL] [Abstract][Full Text] [Related]
18. Use of in-die powder densification parameters in the implementation of process analytical technologies for tablet production on industrial scale.
Cespi M; Perinelli DR; Casettari L; Bonacucina G; Caporicci G; Rendina F; Palmieri GF
Int J Pharm; 2014 Dec; 477(1-2):140-7. PubMed ID: 25304091
[TBL] [Abstract][Full Text] [Related]
19. Use of a continuous twin screw granulation and drying system during formulation development and process optimization.
Vercruysse J; Peeters E; Fonteyne M; Cappuyns P; Delaet U; Van Assche I; De Beer T; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2015 Jan; 89():239-47. PubMed ID: 25528462
[TBL] [Abstract][Full Text] [Related]
20. Impact testing as a new approach to determine mechanical strength of pharmaceutical tablets.
Alhusban F; Murgatroyd EF
Int J Pharm; 2024 Mar; 653():123891. PubMed ID: 38346603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
